{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:05:35Z","timestamp":1772136335201,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07631"],"award-info":[{"award-number":["JP23K07631"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22050-x","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:02:11Z","timestamp":1763114531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual use of combustible and heated tobacco products associates persistent symptoms with a history of COVID-19: a JASTIS 2023 cross\u2011sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Erika","family":"Toyokura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaho","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"22050_CR1","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/vaccines12111264","volume":"12","author":"S Odani","year":"2024","unstructured":"Odani, S., Honda, H. & Tabuchi, T. Association of COVID-19 vaccine intake with diagnosis, hospitalization, and oxygenation\/ventilation: A longitudinal Analysis, 2021\u20132022, Japan. Vaccines 12, 1264. https:\/\/doi.org\/10.3390\/vaccines12111264 (2024).","journal-title":"Vaccines (Basel)"},{"key":"22050_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.resinv.2022.12.011","volume":"61","author":"K Kobayashi","year":"2023","unstructured":"Kobayashi, K. et al. COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan. Respir. Investig. 61, 230\u2013239 (2023).","journal-title":"Respir Investig"},{"key":"22050_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/10105395241305929","volume":"37","author":"A Takamatsu","year":"2025","unstructured":"Takamatsu, A. et al. Changes in personal behaviors during and after the COVID-19 pandemic: A nationwide three-year longitudinal study in Japan. Asia Pac. J. Public Health 37, 108\u2013115 (2025).","journal-title":"Asia Pac. J. Public. Health"},{"key":"22050_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/vaccines12111264","volume":"12","author":"H Honda","year":"2024","unstructured":"Honda, H. et al. Association of individual behaviors with infection prevention measures and COVID-19 development: A Japanese cross-sectional study. Asia Pac. J. Public Health 12, 1264. https:\/\/doi.org\/10.3390\/vaccines12111264 (2024).","journal-title":"Asia Pac. J. Public. Health"},{"key":"22050_CR5","doi-asserted-by":"crossref","unstructured":"Lipscy, P. Y. Japan\u2019s Response to the COVID-19 Pandemic in Japan Decides 2021 (ed. Pekkanen, R. J. et al. ) 239\u2013254 (2021).","DOI":"10.1007\/978-3-031-11324-6_16"},{"key":"22050_CR6","doi-asserted-by":"publisher","unstructured":"Buckell, J. et al. COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-023-34244-2 (2023).","DOI":"10.1038\/s41598-023-34244-2"},{"key":"22050_CR7","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021)."},{"key":"22050_CR8","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","volume":"391","author":"EW Ely","year":"2024","unstructured":"Ely, E. W., Brown, L. M., Fineberg, H. V & The National Academies of Sciences, Engineering, and Medicine Committee on Examining the Working Definition for Long Covid. Long covid defined. N. Engl. J. Med. 391, 1746\u20131753 (2024).","journal-title":"N Engl. J. Med."},{"key":"22050_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601\u2013615 (2021).","journal-title":"Nat. Med."},{"key":"22050_CR10","doi-asserted-by":"publisher","first-page":"100908","DOI":"10.1016\/j.lanepe.2024.100908","volume":"40","author":"O Carlile","year":"2024","unstructured":"Carlile, O. et al. Impact of long COVID on health-related quality-of-life: An opensafely population cohort study using patient-reported outcome measures (OpenPROMPT). Lancet Reg. Health Eur. 40, 100908. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100908 (2024).","journal-title":"Lancet Reg. Health Eur."},{"issue":"e4","key":"22050_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.amjmed.2023.04.040","volume":"138","author":"H Honda","year":"2025","unstructured":"Honda, H. et al. Prolonged symptoms after COVID-19 in Japan: A nationwide survey of the symptoms and their impact on patients\u2019 quality of life. Am. J. Med. 138(e4), 98\u2013107. https:\/\/doi.org\/10.1016\/j.amjmed.2023.04.040 (2025).","journal-title":"Am. J. Med."},{"key":"22050_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jiac.2024.02.008","volume":"30","author":"A Takamatsu","year":"2024","unstructured":"Takamatsu, A. et al. Prevalence and trends in persistent symptoms following COVID-19 in Japan: A nationwide cross-sectional survey. J. Infect. Chemother. 30, 725\u2013733 (2024).","journal-title":"J. Infect. Chemother."},{"key":"22050_CR13","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.1038\/s41598-023-36995-4","volume":"13","author":"Y Kim","year":"2023","unstructured":"Kim, Y., Bae, S., Chang, H. & Kim, S. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci. Rep. 13, 11207. https:\/\/doi.org\/10.1038\/s41598-023-36995-4 (2023).","journal-title":"Sci. Rep."},{"key":"22050_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E. et al. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"22050_CR15","doi-asserted-by":"publisher","unstructured":"Imoto, W. et al. A cross-sectional, multicenter survey of the prevalence and risk factors for long COVID. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-022-25398-6 (2022).","DOI":"10.1038\/s41598-022-25398-6"},{"key":"22050_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cmi.2023.10.016","volume":"30","author":"D Luo","year":"2024","unstructured":"Luo, D. et al. Prevalence and risk factors for persistent symptoms after COVID-19: A systematic review and meta-analysis. Clin. Microbiol. Infect. 30, 328\u2013335 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"22050_CR17","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S. A. et al. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: A systematic review. Lancet Glob. Health 11, e1713-e1724 (2023).","DOI":"10.1016\/S2214-109X(23)00384-4"},{"key":"22050_CR18","doi-asserted-by":"publisher","first-page":"e2238804","DOI":"10.1001\/jamanetworkopen.2022.38804","volume":"5","author":"RH Perlis","year":"2022","unstructured":"Perlis, R. H. et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open. 5, e2238804. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.38804 (2022).","journal-title":"JAMA Netw. Open."},{"key":"22050_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.amjms.2023.04.018","volume":"366","author":"K Kamata","year":"2023","unstructured":"Kamata, K. et al. Post-COVID health-related quality of life and somatic symptoms: A National survey in Japan. Am. J. Med. Sci. 366, 114\u2013123 (2023).","journal-title":"Am. J. Med. Sci."},{"key":"22050_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/jpm14010097","volume":"14","author":"AC Antigona Carmen Trofor","year":"2024","unstructured":"Antigona Carmen Trofor, A. C. et al. Looking at the data on smoking and Post-COVID-19 Syndrome-A literature review. J. Pers. Med. 14, 97. https:\/\/doi.org\/10.3390\/jpm14010097 (2024).","journal-title":"J. Pers. Med."},{"key":"22050_CR21","doi-asserted-by":"publisher","first-page":"16402","DOI":"10.20452\/pamw.16402","volume":"133","author":"G Lippi","year":"2023","unstructured":"Lippi, G., Gomar, F. S. & Henry, B. M. COVID-19 and its long-term sequelae: What do we know in 2023? Pol. Arch. Intern. Med. 133, 16402. https:\/\/doi.org\/10.20452\/pamw.16402 (2023).","journal-title":"Pol. Arch. Intern Med"},{"key":"22050_CR22","doi-asserted-by":"publisher","first-page":"e42315","DOI":"10.2196\/42315","volume":"9","author":"MC Wong","year":"2023","unstructured":"Wong, M. C. Epidemiology, symptomatology, and risk factors for long COVID symptoms: Population-based, multicenter study. JMIR Public Health Surveill. 9, e42315. https:\/\/doi.org\/10.2196\/42315 (2023).","journal-title":"JMIR Public. Health Surveill"},{"key":"22050_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2188\/jea.JE20190199","volume":"30","author":"A Kinjo","year":"2020","unstructured":"Kinjo, A. et al. Heated tobacco product smokers in Japan identified by a population-based survey. J. Epidemiol. 30, 547\u2013555 (2020).","journal-title":"J. Epidemiol."},{"key":"22050_CR24","doi-asserted-by":"publisher","first-page":"102031","DOI":"10.1016\/j.pmedr.2022.102031","volume":"30","author":"S Odani","year":"2022","unstructured":"Odani, S. & Tabuchi, T. Prevalence and denial of current tobacco product use: Combustible and heated tobacco products, Japan, 2022. Prev. Med. Rep. 30, 102031 (2022).","journal-title":"Prev. Med. Rep."},{"key":"22050_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/toxics11080667","volume":"11","author":"S Upadhyay","year":"2023","unstructured":"Upadhyay, S. et al. Heated tobacco products: Insights into composition and toxicity. Toxics 11, 667. https:\/\/doi.org\/10.3390\/toxics11080667 (2023).","journal-title":"Toxics"},{"key":"22050_CR26","doi-asserted-by":"publisher","first-page":"s30","DOI":"10.1136\/tobaccocontrol-2018-054321","volume":"27","author":"GS Helen","year":"2018","unstructured":"Helen, G. S., Iii, P. J., Nardone, N. & Benowitz, N. L. IQOS: Examination of Philip Morris international\u2019s claim of reduced exposure. Tob. Control 27, s30\u2013s36. https:\/\/doi.org\/10.1136\/tobaccocontrol-2018-054321 (2018).","journal-title":"Tob. Control"},{"key":"22050_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1158\/1055-9965.EPI-24-0836","volume":"34","author":"CR Miller","year":"2025","unstructured":"Miller, C. R. et al. Biomarkers of exposure to nicotine and selected toxicants in individuals who use alternative tobacco products sold in Japan and Canada from 2018 to 2019. Cancer Epidemiol. Biomark. Prev. 34, 298\u2013307 (2025).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"22050_CR28","unstructured":"World Health Organization. Heated tobacco products: Information sheet. Report No.: WHO\/HEP\/HPR\/2020.2. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/331297 (2020)."},{"key":"22050_CR29","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41598-023-28006-3","volume":"13","author":"M Nishimura","year":"2023","unstructured":"Nishimura, M. et al. Association of combustible cigarettes and heated tobacco products use with SARS-CoV-2 infection and severe COVID-19 in Japan: A JASTIS 2022 cross-sectional study. Sci. Rep. 13, 1120. https:\/\/doi.org\/10.1038\/s41598-023-28006-3 (2023).","journal-title":"Sci. Rep."},{"key":"22050_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2188\/jea.JE20180116","volume":"29","author":"T Tabuchi","year":"2019","unstructured":"Tabuchi, T. et al. Study profile: The Japan society and new tobacco internet survey (JASTIS): A longitudinal internet cohort study of Heat-Not-Burn tobacco products, electronic Cigarettes, and conventional tobacco products in Japan. J. Epidemiol. 29, 444\u2013450 (2019).","journal-title":"J. Epidemiol."},{"key":"22050_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh, T., Sivan, M., Perlowski, A. & Nikolich, J. \u017d. Long COVID: A clinical update. Lancet 404, 707\u2013724 (2024).","journal-title":"Lancet"},{"key":"22050_CR32","doi-asserted-by":"publisher","first-page":"210185","DOI":"10.1183\/16000617.0185-2021","volume":"31","author":"D Montani","year":"2022","unstructured":"Montani, D. et al. Post-acute COVID-19 syndrome. Eur. Respir. Rev. 31, 210185. https:\/\/doi.org\/10.1183\/16000617.0185-2021 (2022).","journal-title":"Eur. Respir Rev."},{"key":"22050_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0049124108327128","volume":"37","author":"M Schonlau","year":"2009","unstructured":"Schonlau, M., Soest, A., Kapteyn, A. & Couper, M. Selection bias in web surveys and the use of propensity scores. Sociol. Methods Res. 37, 291. https:\/\/doi.org\/10.1177\/0049124108327128 (2009).","journal-title":"Sociol. Methods Res."},{"key":"22050_CR34","unstructured":"Japan Ministry of Health, Labour and Welfare. Overview of the 2016 Comprehensive Survey of Living Condition of the People on Health and Welfare. Available online at: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-tyosa\/k-tyosa16\/index.html. Accessed 19 Dec 2022 (2016)."},{"key":"22050_CR35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/add.13231","volume":"111","author":"T Tabuchi","year":"2016","unstructured":"Tabuchi, T. et al. Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan. Addiction 111, 706\u2013713 (2016).","journal-title":"Addiction"},{"key":"22050_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.2442013","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.2442013 (2013).","journal-title":"Bone Marrow Transpl."},{"key":"22050_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01410768211032850","volume":"114","author":"OL Aiyegbusi","year":"2021","unstructured":"Aiyegbusi, O. L. et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 114, 428\u2013442 (2021).","journal-title":"J. R Soc. Med."},{"key":"22050_CR38","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28, 1706\u20131714 (2022).","journal-title":"Nat. Med."},{"key":"22050_CR39","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S1470-2045(21)00573-8","volume":"22","author":"DJ Pinato","year":"2021","unstructured":"Pinato, D. J. et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: Evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 22, 1669\u20131680 (2021).","journal-title":"Lancet Oncol."},{"key":"22050_CR40","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.jaut.2022.102991","volume":"135","author":"ET Jacobs","year":"2023","unstructured":"Jacobs, E. T. et al. Pre-existing conditions associated with post-acute sequelae of COVID-19. J. Autoimmun. 135, 102991. https:\/\/doi.org\/10.1016\/j.jaut.2022.102991 (2023).","journal-title":"J. Autoimmun."},{"key":"22050_CR41","doi-asserted-by":"publisher","first-page":"e054598","DOI":"10.1136\/bmjopen-2021-054598","volume":"12","author":"HQM Tan","year":"2022","unstructured":"Tan, H. Q. M. et al. Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: A cohort study. BMJ Open 12, e054598. https:\/\/doi.org\/10.1136\/bmjopen-2021-054598 (2022).","journal-title":"BMJ Open."},{"key":"22050_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/tobaccocontrol-2020-055652","volume":"30","author":"A Hori","year":"2020","unstructured":"Hori, A., Tabuchi, T. & Kunugita, N. Rapid increase in heated tobacco product (HTP) use from 2015 to 2019: From the Japan \u2018Society and new tobacco\u2019 internet survey (JASTIS). Tob. Control 30, 474\u2013475 (2020).","journal-title":"Tob. Control"},{"key":"22050_CR43","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US). Office on Smoking and Health. The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General (Centers for Disease Control and Prevention (US), 2014). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179276\/."},{"key":"22050_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5834\/jdh.71.1_11","volume":"71","author":"Ayaka","year":"2021","unstructured":"Ayaka et al. Why people use heated tobacco products in Japan. J. Dent. Health 71, 11\u201318. https:\/\/doi.org\/10.5834\/jdh.71.1_11 (2021). (in Japanese).","journal-title":"J. Dent. Hlth"},{"key":"22050_CR45","doi-asserted-by":"publisher","first-page":"s30","DOI":"10.1136\/tobaccocontrol-2018-054321","volume":"27","author":"G Helen","year":"2018","unstructured":"Helen, G., St., Lii, P. J., Nardone, N. & Benowitz, N. L. IQOS: Examination of Philip Morris international\u2019s claim of reduced exposure. Tob. Control 27, s30\u2013s36. https:\/\/doi.org\/10.1136\/tobaccocontrol-2018-054321 (2018).","journal-title":"Tob. Control"},{"key":"22050_CR46","doi-asserted-by":"publisher","first-page":"00558","DOI":"10.1183\/23120541.00558-2022","volume":"9","author":"P Saha","year":"2023","unstructured":"Saha, P. et al. The effects of dual IQOS and cigarette smoke exposure on airway epithelial cells: Implications for lung health and respiratory disease pathogenesis. ERJ Open Res. 9, 00558\u20132022. https:\/\/doi.org\/10.1183\/23120541.00558-2022 (2023).","journal-title":"ERJ open. Res."},{"key":"22050_CR47","unstructured":"The National Health and Nutrition Survey in Japan. Available from https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/eiyou\/r1-houkoku_00002.html (2019)."},{"key":"22050_CR48","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/ijerph17103570","volume":"17","author":"KM Cummings","year":"2020","unstructured":"Cummings, K. M., Nahhas, G. J. & Sweanor, D. T. What is accounting for the rapid decline in cigarette sales in Japan? Int. J. Environ. Res. Public Health 17, 3570. https:\/\/doi.org\/10.3390\/ijerph17103570 (2020).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"22050_CR49","doi-asserted-by":"publisher","unstructured":"Chu, S. et al. Impact of heating conventional cigarettes with a novel device on Health-related biomarkers and cigarette use patterns among Chinese adult smokers unwilling to quit: A pilot randomized controlled trial. Nicotine Tob. Res.. https:\/\/doi.org\/10.1093\/ntr\/ntae177 (2024).","DOI":"10.1093\/ntr\/ntae177"},{"key":"22050_CR50","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/tc-2022-057598","volume":"33","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Cigarettes, heated tobacco products and dual use: Exhaled carbon monoxide, saliva cotinine and total tobacco consumed by Hong Kong tobacco users. Tob. Control 33, 457\u2013463 (2024).","journal-title":"Tob. Control"},{"key":"22050_CR51","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00902-2024","author":"J Hamoud","year":"2024","unstructured":"Hamoud, J. et al. A systematic review investigating the impact of dual use of E-Cigarettes and conventional cigarettes on smoking cessation. ERJ Open. Res. https:\/\/doi.org\/10.1183\/23120541.00902-2024 (2024).","journal-title":"ERJ Open. Res. Preprint at."},{"key":"22050_CR52","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/psyp.12241","volume":"51","author":"M Nakajima","year":"2014","unstructured":"Nakajima, M. & Al\u2019Absi, M. Nicotine withdrawal and Stress-Induced changes in pain sensitivity: A cross-sectional investigation between abstinent smokers and nonsmokers. Psychophysiology 51, 1015\u20131022 (2014).","journal-title":"Psychophysiology"},{"key":"22050_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18332\/tid\/1502952022","volume":"20","author":"H Barth\u00e9l\u00e9my","year":"2022","unstructured":"Barth\u00e9l\u00e9my, H. et al. Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey. Tob. Induc. Dis. 20, 59. https:\/\/doi.org\/10.18332\/tid\/1502952022 (2022).","journal-title":"Tob. Induc. Dis."},{"key":"22050_CR54","doi-asserted-by":"publisher","first-page":"e28316","DOI":"10.1002\/jmv.28316","volume":"95","author":"K Takakura","year":"2022","unstructured":"Takakura, K., Suka, M., Kajihara, M. & Koido, S. Clinical features, therapeutic outcomes, and recovery period of long COVID. J. Med. Virol. 95, e28316. https:\/\/doi.org\/10.1002\/jmv.28316 (2022).","journal-title":"J. Med. Virol."},{"key":"22050_CR55","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.3390\/ijerph191711093","volume":"19","author":"D Buonsenso","year":"2022","unstructured":"Buonsenso, D. et al. Post-Acute COVID-19 sequelae in a working population at one year follow-up: A wide range of impacts from an Italian sample. Int. J. Environ. Res. Public Health 19, 11093. https:\/\/doi.org\/10.3390\/ijerph191711093 (2022).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"22050_CR56","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1186\/s12889-022-14123-7","volume":"22","author":"E Paul","year":"2022","unstructured":"Paul, E. & Fancourt, D. Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: A longitudinal analysis of 1581 UK adults. BMC Public. Health 22, 1716. https:\/\/doi.org\/10.1186\/s12889-022-14123-7 (2022).","journal-title":"BMC Public. Health"},{"key":"22050_CR57","doi-asserted-by":"publisher","first-page":"100373","DOI":"10.1016\/j.lanepe.2022.100373","volume":"17","author":"MK So","year":"2022","unstructured":"So, M. K., Chu, A. M. & Tiwai, A. Persistent symptoms after SARS-CoV-2 infection: Long-term implications for health and quality of life. Lancet Reg. Health Eur. 17, 100373 (2022).","journal-title":"Lancet Reg. Health Eur."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22050-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:02:15Z","timestamp":1763114535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22050-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22050"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22050-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6669862\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazuhisa Asai reports receiving lecture fees from AstraZeneca, GlaxoSmithKline and Sanofi; Tetsuya Watanabe, receiving lecture fees from AstraZeneca, GlaxoSmithKline and Sanofi; Takahiro Tabuchi receiving financial support for research, (consulting fees and lecture fees) from Daiichi Sankyo Healthcare Co., Ltd., Johnson and Johnson K. K., Data Seed Inc. and Workout-Plus LLC, and grants from the Ministry of Health Labour and Welfare, and Japan Society for the Promotion of Science.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38659"}}